home / stock / imvt / imvt quote
Last: | $28 |
---|---|
Change Percent: | -0.79% |
Open: | $28.19 |
Close: | $28 |
High: | $28.81 |
Low: | $27.78 |
Volume: | 936,848 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$28 | $28.19 | $28 | $28.81 | $27.78 | 936,848 | 07-22-2024 |
$27.97 | $28.47 | $27.97 | $28.88 | $27.78 | 778,057 | 07-19-2024 |
$28.41 | $29.95 | $28.41 | $29.95 | $28.06 | 1,286,789 | 07-18-2024 |
$29.98 | $30.49 | $29.98 | $30.86 | $29.3 | 729,089 | 07-17-2024 |
$30.92 | $30.82 | $30.92 | $31.359 | $30.28 | 850,577 | 07-16-2024 |
$30.51 | $30.77 | $30.51 | $31.07 | $30.065 | 1,304,485 | 07-15-2024 |
$30.57 | $30.88 | $30.57 | $30.88 | $30.03 | 1,202,970 | 07-12-2024 |
$30.34 | $30.89 | $30.34 | $32 | $29.97 | 1,976,278 | 07-11-2024 |
$30.35 | $30.1 | $30.35 | $30.48 | $29.645 | 1,039,444 | 07-10-2024 |
$29.7 | $27.57 | $29.7 | $29.71 | $27.425 | 1,686,783 | 07-09-2024 |
$27.65 | $27.12 | $27.65 | $27.84 | $26.74 | 724,214 | 07-08-2024 |
$26.885 | $26.04 | $26.885 | $26.995 | $25.96 | 603,169 | 07-05-2024 |
$26.2 | $26.7 | $26.2 | $27.09 | $25.95 | 368,979 | 07-04-2024 |
$26.2 | $26.7 | $26.2 | $27.09 | $25.95 | 368,979 | 07-03-2024 |
$26.52 | $27.51 | $26.52 | $27.84 | $26.25 | 625,157 | 07-02-2024 |
$27.51 | $26.39 | $27.51 | $28.64 | $26.26 | 1,383,102 | 07-01-2024 |
$26.4 | $26.13 | $26.4 | $26.58 | $25.59 | 1,743,676 | 06-28-2024 |
$26 | $26.14 | $26 | $26.37 | $25.82 | 794,067 | 06-27-2024 |
$26.06 | $27.09 | $26.06 | $27.19 | $25.865 | 1,469,197 | 06-26-2024 |
$27.29 | $27.22 | $27.29 | $27.54 | $26.97 | 882,471 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
2024-07-12 10:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-12 13:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Following a recently completed Type B meeting with the FDA, Immunovant is on track to initiate 4 to 5 potentially registrational studies for its lead asset IMVT-1402 in endocrinology, neurology, and other therapeutic areas over this fiscal year ending March 31, 2025 Topline data from the bato...